ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,433.74
0.23%
Dow Jones
38,647.10
-0.17%
US Dollar vs MXN
18.46674
0.24%
Brent Oil
82.26
0.35%
Bitcoin
66,952.62
0.29%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
Símbolo:
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
14/06/202402:00Business WireELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple MyelomaNYSE:PFEPfizer Inc
14/06/202402:00GlobeNewswire Inc.Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investigational Base Editing Therapeutic for Sickle Cell DiseaseNASDAQ:BEAMBeam Therapeutics Inc
14/06/202402:00GlobeNewswire Inc.Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patients with Transfusion-dependent Beta Thalassemia, Presented at the European Hematology Association (EHA) Annual CongressNASDAQ:EDITEditas Medicine Inc
14/06/202402:00Business WireImmune-Onc Therapeutics to Present Additional Positive Interim Data from IO-202 Phase 1b Expansion Cohort in Patients with Chronic Myelomonocytic Leukemia (CMML) at 2024 European Hematology Association (EHA) Annual Congress
14/06/202402:00Business WireNew Kite Clinical Research and Real-World Evidence for Yescarta® Demonstrate Benefit From Earlier Lines of TreatmentNASDAQ:GILDGilead Sciences Inc
14/06/202402:00GlobeNewswire Inc.Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimilar), at the European Hematology Association (EHA) Congress 2024
14/06/202402:00PR Newswire (US)Brickken is selected to participate in the European Blockchain Regulatory Sandbox
14/06/202402:00PR Newswire (US)Top tips for retail store remodeling from the Paso Robles general contractor
14/06/202402:00PR Newswire (US)Protecting the vulnerable--Atascadero estate planning attorney on guardianships and conservatorships
14/06/202402:00PR Newswire (US)Getting a divorce when a spouse is missing, tips from We Help You Legal
14/06/202401:46Alliance NewsAlliance NewsLONDON BRIEFING: Bellway's planned takeover of Crest gets rejected
14/06/202401:46Alliance NewsAlliance NewsBridgerton boosts UK economy by GBP275 million, Netflix saysLSE:0QYINetflix Inc
14/06/202401:46PR Newswire (US)Expats soak up Duanwu fun in Shandong
14/06/202401:39Alliance NewsAlliance NewsSunak to tell G7 reform needed for sustainable development and AI
14/06/202401:36Alliance NewsAlliance NewsIrish election results complete after days of counting
14/06/202401:31Alliance NewsAlliance NewsDR Congo weighs legal move against Apple in mining disputeLSE:0R2VApple Inc
14/06/202401:30GlobeNewswire Inc.Renault Group: Implementation of the share buyback programmeBIT:RNORenault SA
14/06/202401:30GlobeNewswire Inc.Renault Group: Mise en œuvre du programme de rachat d’actionsBIT:RNORenault SA
14/06/202401:30GlobeNewswire Inc.Vertex erwirbt Steuerfähigkeiten im Bereich der künstlichen Intelligenz von Ryan, LLCTG:56XVertex Inc
14/06/202401:29PR Newswire (US)The Safavi Impact Institute Sponsors NASA's Space Center Houston's pilot education program in Austria
14/06/202401:25GlobeNewswire Inc.RAMSAY SANTE :reprise des centres CosemLSE:0OD6Ramsay Generale De Sante Sa
14/06/202401:25GlobeNewswire Inc.RAMSAY SANTE :Cosem medical centers takeoverEU:GDSRamsay Generale De Sante
14/06/202401:22Alliance NewsAlliance NewsSerabi Gold "very optimistic" for rest of 2024; hails Coringa activityLSE:SRBSerabi Gold Plc
14/06/202401:13PR Newswire (US)Askel Healthcare to Present First Clinical Trial Results of Its COPLA® Knee Cartilage Implant at the 9th Joint Preservation Congress in Warsaw, Poland on June 14-15, 2024
14/06/202401:11Alliance NewsAlliance NewsTOP NEWS: Tesla shareholders back huge payout for Musk, company saysLSE:0R0XTesla Inc
14/06/202401:09CointelegraphAltcoins signal buy after taking it ‘on the chin’ since MarchCOIN:FOURRUSDFour
14/06/202401:08Business WireIl programma di prove del Cessna Citation Ascend va sempre più in alto con il volo coronato dal successo del secondo modello di provaNYSE:TXTTextron Inc
14/06/202401:07Business WirePrograma de testes Cessna Citation Ascend avança à medida que o segundo artigo de testes de voo decola com sucessoNYSE:TXTTextron Inc
14/06/202401:07Business WireLe programme d'essais du Cessna Citation Ascend poursuit son avancée après le succès du second article testé en volNYSE:TXTTextron Inc
14/06/202401:00GlobeNewswire Inc.Fingerprints and Italy-based WiBioCard partner up for smart card solutionsTG:FPQ1Fingerprint Cards AB

Su Consulta Reciente

COIN
BTCUSD
Bitcoin
USOTC
ADDYY
Adidas (QX)
FX
EURUSD
Euro vs US Dollar
NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
EURMXN
Euro vs MXN
CCOM
US30
US 30
NYSE
BAC
Bank of America
NYSE
CVX
Chevron
NASDAQ
GOOGL
Alphabet
NYSE
XOM
Exxon Mobil
USOTC
BNPQY
BNP Paribas (QX)
SPI
SP500
S&P 500
NYSE
VZ
Verizon Communications
NASDAQ
AAPL
Apple
NASDAQ
MSFT
Microsoft
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados